​Anger is a specific form of the stress response that recruits the same core physiological systems as stress in general (i.e., sympathetic nervous system and HPA axis), but it biases them toward approach, confrontation, and action rather than withdrawal. 
 
When you become angry, the brain detects threat and recruits classic stress circuitry. The amygdala rapidly evaluates a situation as threatening or unjust and signals the hypothalamus. The hypothalamus–pituitary–adrenal (HPA) axis releases CRH, ACTH and then cortisol, while the sympathetic nervous system releases adrenaline and noradrenaline. Heart rate, blood pressure, breathing rate, and body temperature rise; blood is shunted to skeletal muscles, and sweating increases, preparing for fight. This anger arousal sharpens some forms of attention and action readiness, but it can simultaneously impair more complex cognitive processing and decision-making. In that sense, anger is not separate from stress; it is a stress response pattern with a particular motivational direction (attack/approach).
 
Experimental work suggests that anger and fear under stress have different biological signatures, even though both are stressful. Baseline tendencies toward anger and fear are both associated with higher cortisol and pro‑inflammatory cytokines. During an acute laboratory stressor, greater anger reactions predict larger cortisol increases over time, consistent with mobilizing metabolic fuel for action. Greater fear reactions, in contrast, predict increased pro‑inflammatory cytokines but decreased cortisol, aligning more with withdrawal and conservation rather than confrontation. This supports a functional view that different emotions during stress orchestrate distinct temporal patterns in stress biology, tuning the organism either for engagement (anger) or retreat (fear).
 
Acute anger episodes are usually transient and biologically adaptive, but repeated or chronic anger becomes a pathological stress load. Even brief, experimentally induced anger (around 8 minutes) can impair endothelial function, reducing the ability of blood vessels to dilate appropriately. Recurrent anger episodes are thought to have cumulative vascular effects, contributing over time to atherosclerosis, heart attack, and stroke risk. Chronic anger and hostility are associated with sustained elevations in blood pressure and stress hormones, sleep disturbance, and increased risk for cardiovascular disease and other stress‑related conditions. From a psychophysiological perspective, chronic anger effectively means that the organism remains in a prolonged fight‑ready stress state, which the cardiovascular and immune systems are not designed to sustain indefinitely.
 
Anger‑driven stress responses also reshape cognition and behaviour. Subliminal or subtle anger primes can raise systolic blood pressure and slow reaction times on semantic decision tasks, reflecting interference from visceral arousal. Anger states reduce activation in visual and attentional networks, suggesting that resources are reallocated toward internal arousal and motor readiness rather than careful perceptual analysis. Clinically, this translates into a propensity for impulsive speech and action, narrowed perspective, and difficulty engaging in reflective or mentalizing modes under anger. This is one reason anger feels compelling: the stress physiology that supports it biases processing toward immediate action at the cost of nuanced evaluation.
 
Because anger is embedded in stress circuitry, interventions that reduce physiological arousal or modify appraisal can attenuate both. Cognitive‑behavioral therapy for anger targets hostile attribution biases and catastrophic appraisals, helping individuals reinterpret triggers and break automatic anger‑stress chains. Relaxation strategies (slow diaphragmatic breathing, progressive muscle relaxation) reduce sympathetic activation and support prefrontal regulation over limbic responses. Time‑out and withdrawal from triggering environments, when possible, prevent further stressor exposure while arousal is high, allowing the physiological stress response to return toward baseline.
 
An illustrative way to frame it: anger is a stress‑response programme optimized for fighting or confronting obstacles; therapeutic work often involves teaching the system alternative programmes, such as problem‑solving, assertive communication, or disengagement, that can run instead of the default anger pattern in response to stress.
 
References
Fowler, C.H., Bogdan, R. & Gaffrey, M.s. (2021, April 22). Stress-Induced Cortisol Response is Associated with Right Amygdala Volume in Early Childhood.Neurobiology of Stress.
 
Garfinkel, S.N., Zorab, E., Navaratnam, N., Engels, M., Mallorqui-Bague, N., et al. (2015, August 7). Anger in Brain and Body: The Neural and Physiological Perturbation of Decision-Making by Emotion. Social Cognitive and Affective Neuroscience.
 
Lally, R. (2024, May 9). Why Anger is Bad for Your Heart. Columbia University Irving Medical Center.
 
Moons, W.G., Eisenberger, N.I. & Taylor, S.E. (2010, February). 24(2):215-9. Anger and Fear Responses to Stress Have Different Biological Profiles. Brain, Behavior, and Immunity.
 
Simic, G., Tkalcic, M., Vukic, V., Mulc, D., Spanic, E., et al. (2021, May 31). Understanding Emotions: Origins and Roles of the Amygdala. Biomolecules.
 
(2017). How Anger Affects Your Brain and Body. The National Institute for the Clinical Application of Behavioral Medicine. https://www.iahe.com/storage/docs/articles/nicabm-anger-infographic-printable-pdf.pdf

Psychological stress and aging are bidirectionally linked, where chronic stress can accelerate biological and cognitive aging, while aging itself often introduces new stressors that affect mental health.
 
How stress accelerates biological aging
Chronic psychological stress activates the sympathetic nervous system and HPA axis, increasing catecholamines and glucocorticoids such as cortisol, which over time promote inflammation and metabolic dysregulation. Elevated and prolonged cortisol responses are associated with greater leukocyte telomere shortening over several years in mid–late life adults, suggesting faster cellular aging. Furthermore, cortisol can suppress telomerase activity in immune cells, reducing their capacity to maintain telomere length and contributing to shorter telomeres in chronically stressed individuals. Chronic stress is consistently linked with increased pro‑inflammatory cytokine release, contributing to inflammaging, the low‑grade systemic inflammation characteristic of older age.
 
An example: in a longitudinal cohort of adults aged 54–76, those with larger cortisol responses to standardized mental stressors showed greater telomere attrition over three years than low responders.
 
Stress, brain aging, and cognition
Long-term psychological stress is associated with cellular aging in the brain and increased risk of cognitive decline, partly via stress-induced neuroinflammation and altered microglia–neuron interactions. Population-based studies of adults ≥65 show that higher perceived stress predicts lower baseline global cognition and faster cognitive decline over ~7 years, independent of vascular and medical comorbidities. In longitudinal cohorts of older adults, cumulative psychosocial stressors (financial strain, caregiving, disability, chronic illness) are associated with both lower initial cognitive performance and steeper decline over a decade, especially in global cognition and executive function. Emotion regulation moderates these effects, where higher perceived stress predicts worse episodic memory over 10 years mainly in older adults who habitually use expressive suppression, suggesting certain coping styles heighten cognitive vulnerability.
 
Aging as a context of increased stress
Older adults encounter generic life stressors plus age-specific challenges such as losses in functional capacity, chronic pain, multimorbidity, frailty, and the need for long-term care, which increase psychological distress risk. Additional common stressors in late life include bereavement, retirement-related socioeconomic decline, social isolation, and loneliness, all of which are associated with anxiety, depression, and reduced well-being. Mental and neurological disorders account for a substantial fraction of disability in older adults, with around 15% of those ≥60 estimated to have a diagnosable mental disorder, underscoring the clinical impact of stress-related psychopathology in aging.

​Contemporary models propose that when environmental demands chronically exceed coping capacity, repeated activation of stress systems results in allostatic load and drives biological aging processes. Psychological stress and adversity contribute to accelerated aging through at least two major pathways: neuroendocrine activation (SNS/HPA and stress hormones) and inflammation/oxidative stress, both of which feed into telomere dynamics and other aging biomarkers. Across the lifespan, shorter telomeres and reduced telomerase activity have been linked with various stress exposures, from early life adversity to chronic caregiving burden, consistent with a stress–aging continuum.
 
Levers for healthier aging under stress
Evidence from cohort and mechanistic studies suggests that reducing chronic psychosocial stressors (e.g., financial strain, unbuffered caregiving demands) may help preserve cognitive health in later life. Because modifying external stressors is often limited, interventions that target physiological stress responsivity (e.g., reducing exaggerated cortisol responses) are proposed as a way to slow telomere attrition and cellular aging, although this remains an active research area. Psychosocial interventions that reduce perceived stress and shift emotion regulation away from rigid expressive suppression could plausibly mitigate stress-related cognitive decline in older adults.
 
References
 
Aggarwal, N.T., Wilson, R.S., Back, T.L., Rajan, K.B., de Leon, C.F.M., Evans, D.A. & Everson-Rose, S.A. (2013, December 23). Perceived Stress and Change in Cognitive Function Among Adults Aged 65 and Older. Psychosomatic Medicine. 
 
Carrier, M., Simoncicova, E., St-Pierre, M.K., McKee, C. & Tremblay, M.E. (2021, November 4). Psychological Stress as a Risk Factor for Accelerated Cellular Aging and Cognitive Decline: The Involvement of Microglia-Neuron Crosstalk. Frontiers.
 
Jurgens, S., Howard, E., Eistein, D., Prieto, S. & Hayes, J.P. (2025, September 16). Perceived Stress and Cognitive Decline: The Moderating Role of Emotion Regulation. Innovation in Aging.
 
Li, J., Orti-Casan, N., Bayraktaroglu, I., Mozzanica, G., Zhang, F., Olivier, J.D.A. & Eisel, U.L.M. (2025, June 17). Psychosocial Stressors and Cognitive Function: An Analysis Using Data from the English Longitudinal Study of Aging. The Journal of Prevention of Alzheimer’s Disease.
 
Polsky, L.R., Rentscher, K.E. & Carroll, J.E. (2022, May 31). Stress-Induced Biological Aging: A Review and Guide for Research Priorities. Brain, Behavior, and Immunity.
 
Shaley, I., Entringer, S., Wadhwa, P.D., Wolkowitz, O.M., Puterman, E., Lin, J. & Epel, E.S. (2013, April 29). Stress and Telomere Biology: A Lifespan Perspective.Psychoneuroendocrinology.
 
Steptoe, A., Mamer, M., Lin, J., Blackburn, E.H. & Erusalimsky, J.D. (2016, December 14). The Longitudinal Relationship Between Cortisol Responses to Mental Stress and Leukocyte Telomere Attrition. Journal of Clinical Endocrinology Metabolism. 
 
Yegorov, Y.E., Poznyak, A.V., Nikiforov, N.G., Sobenin, I.A. & Orekhov, A.N. (2020, July 7). The Link Between Chronic Stress and Accelerated Aging. Biomedicines.

​Chronic stress is a long-lasting state of feeling under pressure, threatened, or overwhelmed that keeps the body’s stress response activated over an extended period of time (i.e., weeks, months, or longer).
 
Chronic stress is a persistent physiological and psychological response to ongoing stressors, rather than a short, time-limited reaction. The stressors can be external (workload, caregiving, financial strain, conflict, unsafe environments) or internal (worry, rumination, ongoing fear), and they may be real or recalled; both can trigger the same response. Chronic stress keeps the fight‑or‑flight systems (sympathetic nervous system and HPA axis) activated, with prolonged release of hormones such as adrenaline and cortisol. Over time, this allostatic load contributes to high blood pressure, cardiovascular disease, immune dysregulation, metabolic changes, and alterations in brain structures involved in memory, emotion, and decision‑making.
 
Typical causes and contexts for a sustained level of stress factors are the following:
Ongoing circumstances such as high‑pressure jobs, financial difficulties, chronic illness, caregiving responsibilities, or long‑term relationship and family conflict commonly underpin chronic stress.
 
Earlier adverse experiences (for example, abuse, neglect, or household dysfunction in childhood) can predispose people to chronic stress patterns later in life.
 
The common symptoms as a result of this mode of stress level are many:
Psychological: irritability, anxiety, low mood, feeling overwhelmed or helpless, low self‑esteem, social withdrawal, rapid or disorganized thoughts, poor concentration.
 
Physical: headaches, muscle tension or pain, back pain, menstrual problems, digestive issues, fatigue, changes in appetite, frequent infections or illnesses, sleep disturbance.
 
Behavioural: reduced motivation, neglect of self‑care, increased use of alcohol or drugs to cope, changes in sexual desire.
 
Because the stress response is designed for short‑term survival, having it stuck on gradually wears down multiple organ systems and increases risk for anxiety, depression, cardiovascular disease, sleep disorders, and cognitive problems. Identifying chronic stress early and using evidence‑based strategies (lifestyle changes, psychological interventions, social support, sometimes medication) can reduce this risk and improve quality of life.
 
References
(2025, November 9). Chronic Stress. In Wikipedia, https://en.wikipedia.org/wiki/Chronic_stress
 
(2024, May 15). Stress. Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/11874-stress
 
(2024). Chronic Stress. Science Direct. https://www.sciencedirect.com/topics/immunology-and-microbiology/chronic-stress
 
Mayo Clinic Staff. (2023, August 1). Chronic Stress Puts Your Health at Risk. Mayo Clinic. https://www.mayoclinic.org/healthy-lifestyle/stress-management/in-depth/stress/art-20046037

Chronic stress appears to modestly increase cancer risk and worsen outcomes through hormonal, immune, and inflammatory pathways, but it is one factor among many and does not mean stress alone causes cancer. Large reviews find a consistent association between high psychological stress, depression or anxiety and higher overall cancer incidence in the general population. Chronic stress is linked to faster tumour growth, more metastasis, and poorer survival in several cancers (notably breast, ovarian, prostate, lung, and others). The effect size is generally modest compared with major risk factors like smoking or obesity, and not every study finds the same pattern, so stress is best seen as a contributory, not deterministic, factor.
 
Biological mechanisms
Under chronic stress, the hypothalamic–pituitary–adrenal (HPA) axis and sympathetic nervous system stay persistently activated, increasing cortisol and catecholamines (adrenaline, noradrenaline). 
 
The key downstream effects include DNA damage and cell regulation; excess stress hormones can increase oxidative DNA damage; promoting new blood vessel formation, invasion, and metastasis; chronic stress impairs cell‑mediated immunity (e.g., NK cells, cytotoxic T cells) and increases systemic inflammation, reducing immune surveillance against emerging cancer cells; tumour microenvironment changes; stress signaling can reshape the tumor microenvironment, including activation of STAT3/Src and autophagy pathways that support tumour cell survival, angiogenesis, and therapy resistance.
 
Behavioural and psychosocial pathways
Chronic stress also shifts behaviours that independently influence cancer risk.
 
These includes higher rates of smoking, unhealthy diet, alcohol misuse, and physical inactivity under chronic psychological distress; disrupted sleep and circadian rhythms, which are themselves associated with metabolic and immune dysregulation relevant to cancer; lower adherence to screening, treatment, and follow‑up in highly distressed individuals, which can lead to later diagnosis and poorer outcomes. These behavioural factors partially mediate the link between psychological distress and cancer mortality, although inflammation and direct biological effects also play important roles.
 
Can stress reduction change cancer risk or outcomes?
In people with cancer, stress‑management interventions (e.g., cognitive–behavioural therapy, relaxation training) reliably reduce anxiety, depression, and distress, and often improve immune and endocrine markers. Some randomized trials suggest that such interventions may be associated with improved long‑term outcomes (like reduced recurrence or better survival), although these findings are not yet uniform and samples are often small.
 
In lung cancer patients, mindfulness‑based stress reduction reduces cancer‑related fatigue, improves mood, and enhances sleep and quality of life, which may indirectly support better treatment adherence and physical resilience.
 
Practical implications
For reducing cancer risk and supporting health: Address chronic, unrelenting stress through structured approaches (CBT, mindfulness, relaxation training, social support, exercise), especially when combined with standard risk‑reduction (no smoking, healthy weight, physical activity, limited alcohol). If someone already has cancer, integrating psychological and stress‑management care into oncology can improve quality of life and may help immune and endocrine regulation in ways that could influence disease course.
 
References
Abate, m., Citro, M., Caputo, M., Pisanti, S. & Martinelli, R. (2020, October 1). Psychological Stress and Cancer: New Evidence of an Increasingly Strong Link.Translational Medicine, University of Salerno.
 
Antoni, M.H. & Dhabhar. (2019, February 15). Impact of Psychosocial Stress and Stress Management on Immune Responses in Cancer Patients. Cancer.
 
Antoni, M.H., Moreno, P.I. & Penedo, F.J. (2023, January). Stress Management Interventions to Facilitate Psychological and Physiological Adaptation and Optimal Health Outcomes in Cancer Patients and Survivors. Annual Review of Psychology.
 
Cooper, K., Campbell, F., Harnan, S. & Sutton, A. (2023, October 21). Association Between Stress, Depression or Anxiety and Cancer: Rapid Review of Reviews. Comprehensive Psychoneuroendocrinology.
 
Da, S., Mo, Y., Wang, Y., Xiang, B., Liao, Q., et al. (2020, August 19). Chronic Stress Promotes Cancer Development. Frontiers in Oncology.
 
Hong, H., Ji, M. & Lai, D. (2021, December 20). Chronic Stress Effects on Tumor: Pathways and Mechanism. Frontiers in Oncology. 
 
Khan, A., Song, M. & Dong, Z. (2025, July 17). Chronic Stress: A Fourth Etiology in Tumorigenesis? Molecular Cancer.
 
Lazebnik, T. & Aharonson, V. (2025, September 26). Chronic Stress, Immune Suppression, and Cancer Occurrence: Unveiling the Connection Using Survey Data and Predictive Models. Arxiv.
 
Miller, N.E., Pentti, J., Steptoe, A., Kivimaki, M., Lally, P., et al. (2025, December 12). Mediators of the Association Between Psychological Distress and Mortality in People Diagnosed with Cancer. Nature Communications.